The end of the Covid health emergency won’t slow FDA clearance of shots and treatments
The FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines. Source link
Read moreThe FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines. Source link
Read moreTraders are once again piling into stocks with high short interest, and these names could be the next targets of
Read moreThese are the stocks posting the largest moves in midday trading. Source link
Read moreNames on the move ahead of the open. Source link
Read moreThe Maryland biotech company cut its 2022 sales outlook by about 50% and now expects to generate $2 billion to
Read moreNovavax's new Covid vaccine is perfect for people scared of mRNA tech. Here's why experts say many of them still
Read moreUpdating the shots to target omicron could provide more durable protection against the virus, though the data right now is
Read moreU.S. stock futures fell Wednesday after back-to-back gains on Wall Street. Source link
Read moreIf the FDA committee endorses Novavax's shot, the drug regulator is almost certain to rapidly authorize it for use in
Read more